Modified Fan-Shaped Distribution Technology for Computed Tomography (CT)-Guided Radioactive Seed Implantation in Lung Cancer Patients with Lung Dysfunction

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2017 Sep 11

PMID 28889144

Citations 3

Authors

Peng Du

Yueyong Xiao

Wei Lu

Affiliations

Soon will be listed here.

Abstract

BACKGROUND The aim of this study was to investigate the safety and effectiveness of fan-shaped distribution and coaxial puncture technology for radioactive iodine 125 (125I) seed implantation in treatment of lung cancer patients with lung dysfunction. MATERIAL AND METHODS We enrolled and analyzed 33 lung cancer patients with lung dysfunction diagnosed in our hospital from 2013 to 2014 in this study, all of which were implanted with radioactive 125I seed with technology of fan-shaped distribution and coaxial puncture. The matched peripheral dose (MPD) range was 90-140GY. The brachytherapy planning system (TPS) was used to draw up a preoperative seed implantation plan. The fan-shaped distribution system was applied to simulate a surgery program, and seed implantation pitch was 0.5-1.0 cm. Real-time adjustment was necessary during surgery. Dose distributions were verified by TPS immediately after implantation. Intraoperative and postoperative surgery-related complications were analyzed. All patients were followed up for 6 months, and the local control rate of cancer was evaluated through CT scan. RESULTS All patients were operated on successfully. The main surgery-related complications were pulmonary hemorrhage, pleural cavity hemorrhage, and pneumothorax. The local control rates of 2-month, 4-month, and 6-month were 29%, 73%, and 85%, respectively. The total complete remission rate was 18%, the partial response rate was 67%, the stable disease rate was 12%, and the disease progression rate was 3%. CONCLUSIONS The fan-shaped distribution and coaxial puncture technology for radioactive 125I seed implantation was safe and effective in treating lung cancer patients with lung dysfunction.

Citing Articles

I seed implantation for lymph node metastasis from radioactive iodine-refractory differentiated thyroid carcinoma: a study on short-term efficacy and dosimetry.

Zhang W, Hao S, Wang Z, Ding T, Zhang G Front Oncol. 2024; 14:1325987.

PMID: 38988713 PMC: 11233436. DOI: 10.3389/fonc.2024.1325987.

Stereotactic Ablative Brachytherapy: Recent Advances in Optimization of Radiobiological Cancer Therapy.

Xue H, Qiu B, Wang H, Jiang P, Sukocheva O, Fan R Cancers (Basel). 2021; 13(14).

PMID: 34298703 PMC: 8304109. DOI: 10.3390/cancers13143493.

Implantation of computed tomography-guided Iodine-125 seeds in combination with chemotherapy for the treatment of stage III non-small cell lung cancer.

Huo X, Huo B, Wang H, Wang L, Cao Q, Zheng G J Contemp Brachytherapy. 2018; 9(6):527-534.

PMID: 29441096 PMC: 5808001. DOI: 10.5114/jcb.2017.72605.

References

Feng Y, Xiao Y, Li S, Lin M, Zhang Y, Wang H . The treatment of non-small cell lung cancer by interstitial I-125 seeds implantation combined with chemotherapy and Chinese medicine. Chin J Integr Med. 2012; 18(9):663-9. DOI: 10.1007/s11655-012-1203-y. View

Sun Y, Song P, Guo Y, Sheng L . Computed tomography-guided percutaneous microwave ablation therapy for lung cancer. Genet Mol Res. 2015; 14(2):4858-64. DOI: 10.4238/2015.May.11.18. View

Jiang G, Li Z, Ding A, Zhou F, Jiao W, Tang D . Computed tomography-guided iodine-125 interstitial implantation as an alternative treatment option for lung cancer. Indian J Cancer. 2015; 51 Suppl 2:e9-12. DOI: 10.4103/0019-509X.151999. View

Nag S, Dehaan M, Scruggs G, Mayr N, Martin E . Long-term follow-up of patients of intrahepatic malignancies treated with iodine-125 brachytherapy. Int J Radiat Oncol Biol Phys. 2005; 64(3):736-44. DOI: 10.1016/j.ijrobp.2005.08.029. View

Tavares e Castro A, Freitas S, Portilha A, Alves F, Caseiro-Alves F . Efficacy and safety of percutaneous radiofrequency thermal ablation in the treatment of lung cancer lesions. Acta Med Port. 2015; 28(1):63-9. DOI: 10.20344/amp.5620. View

Zhang F, Li C, Jiao D, Zhang N, Wu P, Duan G . CT guided 125iodine seed implantation for portal vein tumor thrombus in primary hepatocellular carcinoma. Chin Med J (Engl). 2008; 121(23):2410-4. View

Shen X, Li Y, Zhang Y, Kong J, Li Y . An analysis of brachytherapy with computed tomography-guided permanent implantation of Iodine-125 seeds for recurrent nonkeratin nasopharyngeal carcinoma. Onco Targets Ther. 2015; 8:991-7. PMC: 4427452. DOI: 10.2147/OTT.S83140. View

van der Noordaa M, Pengel K, Groen E, van Werkhoven E, Rutgers E, Loo C . The use of radioactive iodine-125 seed localization in patients with non-palpable breast cancer: a comparison with the radioguided occult lesion localization with 99m technetium. Eur J Surg Oncol. 2015; 41(4):553-8. DOI: 10.1016/j.ejso.2015.01.022. View

Niu L, Zhou L, Xu K, Mu F . Combination of cryosurgery and Iodine-125 seeds brachytherapy for lung cancer. J Thorac Dis. 2012; 4(5):504-7. PMC: 3461083. DOI: 10.3978/j.issn.2072-1439.2012.09.03. View

10.

Kodama H, Yamakado K, Hasegawa T, Fujimori M, Yamanaka T, Takaki H . Radiofrequency Ablation Using a Multiple-Electrode Switching System for Lung Tumors with 2.0-5.0-cm Maximum Diameter: Phase II Clinical Study. Radiology. 2015; 277(3):895-902. DOI: 10.1148/radiol.2015141153. View

11.

Zhang F, Li C, Wu P, Li K, Huang J, Fan W . [Radioactive seed 125I implantation in treating recurrence and metastasis after liver transplantation in hepatoma]. Zhonghua Yi Xue Za Zhi. 2007; 87(14):956-9. View

12.

Qin Q, Huang B, Tan Q, Yang W, Lian B, Wei C . Radiobiological effect induced by different activities of (125)I seed brachytherapy in a hepatocellular carcinoma model. Int J Clin Exp Med. 2015; 7(12):5260-7. PMC: 4307476. View

13.

Cherian S, Kittel J, Reddy C, Kolar M, Ulchaker J, Angermeier K . Safety and efficacy of iodine-125 permanent prostate brachytherapy in patients with J-pouch anastomosis after total colectomy for ulcerative colitis. Pract Radiat Oncol. 2015; 5(5):e437-e442. DOI: 10.1016/j.prro.2015.03.002. View

14.

Huang Q, Chen J, Chen Q, Lai Q, Cai S, Luo K . Computed tomographic-guided iodine-125 interstitial implants for malignant thoracic tumors. Eur J Radiol. 2013; 82(11):2061-6. DOI: 10.1016/j.ejrad.2013.05.037. View

15.

Zhang X, Tian J, Zhao L, Wu B, Kacher D, Ma X . CT-guided conformal cryoablation for peripheral NSCLC: initial experience. Eur J Radiol. 2012; 81(11):3354-62. DOI: 10.1016/j.ejrad.2012.04.035. View

16.

Niu L, Chen J, Yao F, Zhou L, Zhang C, Wen W . Percutaneous cryoablation for stage IV lung cancer: a retrospective analysis. Cryobiology. 2013; 67(2):151-5. DOI: 10.1016/j.cryobiol.2013.06.005. View

17.

Li W, Guan J, Yang L, Zheng X, Yu Y, Jiang J . Iodine-125 brachytherapy improved overall survival of patients with inoperable stage III/IV non-small cell lung cancer versus the conventional radiotherapy. Med Oncol. 2014; 32(1):395. DOI: 10.1007/s12032-014-0395-8. View

18.

Yang H, Liu Y, Xu L, Liu L . Efficacy of permanent iodine-125 seed implants and gemcitabine chemotherapy in patients with platinum- resistant recurrent ovarian carcinoma. Asian Pac J Cancer Prev. 2014; 15(20):9009-13. DOI: 10.7314/apjcp.2014.15.20.9009. View

19.

Johnson M, Colonias A, Parda D, Trombetta M, Gayou O, Reitz B . Dosimetric and technical aspects of intraoperative I-125 brachytherapy for stage I non-small cell lung cancer. Phys Med Biol. 2007; 52(5):1237-45. DOI: 10.1088/0031-9155/52/5/002. View